William E. Dager

4.7k total citations · 1 hit paper
111 papers, 3.2k citations indexed

About

William E. Dager is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, William E. Dager has authored 111 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cardiology and Cardiovascular Medicine, 61 papers in Internal Medicine and 46 papers in Surgery. Recurrent topics in William E. Dager's work include Venous Thromboembolism Diagnosis and Management (61 papers), Atrial Fibrillation Management and Outcomes (49 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (39 papers). William E. Dager is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (61 papers), Atrial Fibrillation Management and Outcomes (49 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (39 papers). William E. Dager collaborates with scholars based in United States, Canada and Spain. William E. Dager's co-authors include Robert C. Gosselin, Richard H. White, Edith A. Nutescu, A. Joshua Roberts, Brett H. Heintz, Ann K. Wittkowsky, Sarah A. Spinier, Laura Tsu, John T. Owings and Gary R. Matzke and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and American Journal of Kidney Diseases.

In The Last Decade

William E. Dager

110 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Management of Antithrombotic Therapy

2022 146 citations James D. Douketis, Alex C. Spyropoulos et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Dager United States	31	1.6k	1.5k	1.0k	410	358	111	3.2k
John Fanikos United States	35	1.5k 1.0×	1.6k 1.0×	758 0.7×	193 0.5×	146 0.4×	131	3.4k
Robert C. Gosselin United States	38	2.1k 1.4×	1.9k 1.3×	1.0k 1.0×	1.1k 2.6×	395 1.1×	150	4.8k
Sarah A. Spinler United States	28	1.8k 1.1×	805 0.5×	846 0.8×	137 0.3×	129 0.4×	126	3.2k
Daniel M. Witt United States	31	3.1k 1.9×	2.2k 1.5×	610 0.6×	386 0.9×	125 0.3×	153	4.5k
for the Mexican Nephrology Collaborative Study Group United States	18	1.2k 0.7×	375 0.2×	1.8k 1.7×	401 1.0×	145 0.4×	23	4.8k
Henry G. Watson United Kingdom	19	1.1k 0.7×	1.2k 0.8×	559 0.5×	910 2.2×	156 0.4×	37	3.0k
Saurav Chatterjee United States	38	3.0k 1.9×	1.6k 1.1×	956 0.9×	228 0.6×	153 0.4×	153	4.9k
Jeffrey A. Kline United States	38	1.7k 1.1×	1.5k 1.0×	1.2k 1.2×	184 0.4×	1.1k 3.0×	101	5.0k
Ann K. Wittkowsky United States	25	2.0k 1.2×	1.5k 1.0×	506 0.5×	277 0.7×	84 0.2×	69	2.9k
Geoffrey D. Barnes United States	26	1.9k 1.2×	1.9k 1.2×	418 0.4×	142 0.3×	103 0.3×	234	3.4k

Countries citing papers authored by William E. Dager

Since Specialization

Citations

This map shows the geographic impact of William E. Dager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Dager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Dager more than expected).

Fields of papers citing papers by William E. Dager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Dager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Dager. The network helps show where William E. Dager may publish in the future.

Co-authorship network of co-authors of William E. Dager

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Dager. A scholar is included among the top collaborators of William E. Dager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Dager. William E. Dager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roberts, A. Joshua, et al.. (2024). Temporarily Reversing Warfarin With Low-Dose 4-Factor Prothrombin Complex Concentrate in Left Ventricular Assist Device Patients Undergoing an Invasive Procedure. Annals of Pharmacotherapy. 59(1). 5–12.

Dager, William E.. (2023). Developing precision‐based multidisciplinary pharmacotherapy management plans in the critically ill. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(11). 1102–1111. 1 indexed citations

Dager, William E., Toby C. Trujillo, & Brian W. Gilbert. (2023). Approaches to Precision‐based Anticoagulation management in the critically Ill. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(11). 1221–1236. 3 indexed citations

Parrish, Richard H., et al.. (2022). Positive Patient Postoperative Outcomes with Pharmacotherapy: A Narrative Review including Perioperative-Specialty Pharmacist Interviews. Journal of Clinical Medicine. 11(19). 5628–5628. 4 indexed citations

Douketis, James D., Alex C. Spyropoulos, M. Hassan Murad, et al.. (2022). Perioperative Management of Antithrombotic Therapy. CHEST Journal. 162(5). e207–e243. 146 indexed citations breakdown →

Dager, William E., et al.. (2022). Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels. Annals of Pharmacotherapy. 56(12). 1289–1298. 4 indexed citations

Roberts, A. Joshua, et al.. (2021). INR Response to Low-Dose Vitamin K in Warfarin Patients. Annals of Pharmacotherapy. 55(10). 1223–1229. 5 indexed citations

Barnes, Geoffrey D., Allison Burnett, Arthur L. Allen, et al.. (2020). Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. Journal of Thrombosis and Thrombolysis. 50(1). 72–81. 318 indexed citations

Dager, William E., A. Joshua Roberts, & Daniel K. Nishijima. (2018). Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants. Thrombosis Research. 173. 71–76. 30 indexed citations

10.

Dager, William E., et al.. (2017). Incomplete dabigatran reversal with idarucizumab. Clinical Toxicology. 56(3). 216–218. 18 indexed citations

11.

Flannery, Alexander H., et al.. (2017). Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations. Journal of Thrombosis and Thrombolysis. 44(1). 76–87. 14 indexed citations

12.

Roberts, A. Joshua, et al.. (2016). Safety and efficacy of starting warfarin after two consecutive platelet count rises in heparin-induced thrombocytopenia. Thrombosis Research. 144. 229–233. 3 indexed citations

13.

Dager, William E., et al.. (2012). Removal of Dabigatran by Hemodialysis. American Journal of Kidney Diseases. 61(3). 487–489. 123 indexed citations

14.

Dobesh, Paul P., Ann K. Wittkowsky, Zachary A. Stacy, et al.. (2009). Key Articles and Guidelines in the Treatment of Venous Thromboembolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(11). 1385–1385. 10 indexed citations

15.

Dobesh, Paul P., Sara D. Brouse, William E. Dager, et al.. (2007). Key Articles and Guidelines in the Management of Acute Coronary Syndromes and in Percutaneous Coronary Intervention: 2007 Update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12). 1722–1758. 3 indexed citations

16.

Dager, William E., Cynthia A. Sanoski, Barbara S. Wiggins, & James E. Tisdale. (2006). Pharmacotherapy Considerations in Advanced Cardiac Life Support. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(12). 1703–1729. 12 indexed citations

17.

Dager, William E., Judith C. Andersen, & Edith A. Nutescu. (2004). Special Considerations with Fondaparinux Therapy: Heparin‐Induced Thrombocytopenia and Wound Healing. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(7P2). 88S–94S. 23 indexed citations

18.

Dager, William E., Robert C. Gosselin, & John T. Owings. (2004). Argatroban Therapy for Antithrombin Deficiency and Mesenteric Thrombosis: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(5). 659–663. 9 indexed citations

19.

Dager, William E. & Richard H. White. (2003). Pharmacotherapy of heparin-induced thrombocytopenia. Expert Opinion on Pharmacotherapy. 4(6). 919–940. 32 indexed citations

20.

Dager, William E. & Richard H. White. (2002). Treatment of Heparin-Induced Thrombocytopenia. Annals of Pharmacotherapy. 36(3). 489–503. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact